Burkitt cell leukemia following treatmen
โ
S. H. Krikler; Dr. G. O. Bain; P. A. Gordon
๐
Article
๐
1984
๐
John Wiley and Sons
๐
English
โ 577 KB
The development of Burkitt cell leukemia (FABL3) [l] in a patient 7 years after successful treatment of Hodgkin's disease (HD) by combined modality (chemotherapy and radiotherapy) therapy is described. The B-cell nature of the leukemic blasts is shown by immunologic surface marker studies. While L3